In a new study, Yale researchers find that a preexisting cancer drug may also offer a promising therapeutic avenue for atherosclerosis, a common trigger of heart attack and stroke caused by inflammation and plaque buildup in arteries.
[email protected] (Yale News)
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 29
- Comments 0
